Researchers modified the original peptide structure to create longer-acting formulations with various strategies: liraglutide (once daily) uses fatty acid albumin-binding, dulaglutide (once weekly) employs an Fc-fusion approach, exenatide extended-release (Bydureon, once weekly) utilises microsphere technology, and semaglutide (once weekly) incorporates fatty acid modifications
We do not operate like an online dispenser, and this is physician-level care, not a subscription service
Definizione ed individuazione dei fattori di rischio specifici della propria azienda
What is Wegovy used for
(PubMed) Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC
Contact your GP urgently if blood glucose remains consistently above 15 mmol/L or you develop symptoms of hyperglycaemia